Evidence map›Paper›PMID 39063827›Full record

ArticleMaterials (Basel, Switzerland)2024

Study on Key Properties and Model Establishment of Innovative Recycled Aggregate Pervious Concrete.

Panfeng Zhao, Jingfei Zhou, Zhengnan Zhang, Shoukai Chen

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Panfeng ZhaoSinohydro Foundation Engineering Co., Ltd., Tianjin 301700, China.
Jingfei ZhouSchool of Water Conservancy, North China University of Water Resources and Electric Power, Zhengzhou 450046, China.
Zhengnan ZhangNanjing Hydraulic Research Institute, Nanjing 210024, China.
Shoukai ChenSchool of Water Conservancy, North China University of Water Resources and Electric Power, Zhengzhou 450046, China.

Funding

Henan Provincial Science and Technology Research Project 222102320439National Natural Science Foundation of China 51979169National Natural Science Foundation of China 52109154
6 · The paper itself

Abstract

In order to meet the needs of low-impact development and sustainable development, there is an urgent desire to develop an innovative recycled aggregate pervious concrete (I-RAPC) that is of high strength and permeability. In this study, I-RAPC was prepared based on response surface methodology (RSM) using recycled aggregate, river sand, and different types of pipes as the materials, and the effects of different pipe parameters (number, diameter, material, and distribution form) on the performance of I-RAPC were investigated. In addition, the calculation model of the compressive strength and the permeability coefficient of I-RAPC were proposed. The results showed that the frontal- and lateral-compressive strengths of I-RAPC were 39.8 MPa and 42.5 MPa, respectively, when the pipe material was acrylic, the position was 1EM, and the diameter was 10 mm-at which time the permeability coefficient was 3.02 mm/s, which was the highest in this study. The maximum relative errors of the compressive strength calculation model and the permeability coefficient calculation model were only 7.52% and 4.42%, respectively, as shown by the post hoc test. Therefore, I-RAPC has the advantages of high strength and permeability and is expected to be applied in low-impact development in cities with heavy surface sediment content and rainfall.

Indexed as

acrylic pipecompressive strengthinnovative recycled aggregate pervious concretepermeability coefficientresponse surface methodology

Identifiers

PMID39063827
PMCPMC11278775

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.